A detailed history of Forsta Ap Fonden transactions in Abbott Laboratories stock. As of the latest transaction made, Forsta Ap Fonden holds 422,100 shares of ABT stock, worth $48.4 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
422,100
Previous 383,600 10.04%
Holding current value
$48.4 Million
Previous $39.9 Million 20.73%
% of portfolio
0.38%
Previous 0.36%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$100.07 - $118.13 $3.85 Million - $4.55 Million
38,500 Added 10.04%
422,100 $48.1 Million
Q2 2024

Aug 08, 2024

SELL
$100.73 - $112.44 $3.09 Million - $3.45 Million
-30,700 Reduced 7.41%
383,600 $39.9 Million
Q1 2024

May 07, 2024

SELL
$109.52 - $120.96 $3.52 Million - $3.88 Million
-32,100 Reduced 7.19%
414,300 $47.1 Million
Q4 2023

Feb 06, 2024

SELL
$90.19 - $110.4 $3.54 Million - $4.33 Million
-39,200 Reduced 8.07%
446,400 $49.1 Million
Q3 2023

Oct 25, 2023

BUY
$95.53 - $114.62 $1.25 Million - $1.5 Million
13,100 Added 2.77%
485,600 $47 Million
Q2 2023

Aug 03, 2023

SELL
$100.78 - $112.29 $131,014 - $145,977
-1,300 Reduced 0.27%
472,500 $51.5 Million
Q1 2023

Apr 21, 2023

SELL
$96.86 - $114.01 $4.92 Million - $5.79 Million
-50,800 Reduced 9.68%
473,800 $48 Million
Q4 2022

Feb 02, 2023

BUY
$95.06 - $111.52 $9.22 Million - $10.8 Million
97,000 Added 22.68%
524,600 $57.6 Million
Q3 2022

Oct 17, 2022

BUY
$96.76 - $112.03 $6.8 Million - $7.88 Million
70,300 Added 19.68%
427,600 $41.4 Million
Q2 2022

Aug 11, 2022

SELL
$102.07 - $123.37 $2.3 Million - $2.78 Million
-22,500 Reduced 5.92%
357,300 $38.8 Million
Q1 2022

May 09, 2022

BUY
$114.02 - $139.04 $34,206 - $41,712
300 Added 0.08%
379,800 $45 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $4.25 Million - $5.21 Million
36,800 Added 10.74%
379,500 $53.4 Million
Q3 2021

Nov 10, 2021

BUY
$116.66 - $129.06 $1.25 Million - $1.38 Million
10,700 Added 3.22%
342,700 $40.5 Million
Q2 2021

Aug 12, 2021

BUY
$105.79 - $124.53 $4.02 Million - $4.73 Million
38,000 Added 12.93%
332,000 $38.5 Million
Q1 2021

May 11, 2021

SELL
$108.84 - $128.23 $4.3 Million - $5.07 Million
-39,500 Reduced 11.84%
294,000 $35.2 Million
Q4 2020

Feb 09, 2021

BUY
$105.0 - $114.42 $3.48 Million - $3.79 Million
33,100 Added 11.02%
333,500 $36.5 Million
Q3 2020

Oct 22, 2020

BUY
$91.64 - $111.29 $3.54 Million - $4.3 Million
38,600 Added 14.74%
300,400 $32.7 Million
Q2 2020

Aug 11, 2020

BUY
$76.57 - $98.0 $2.2 Million - $2.81 Million
28,700 Added 12.31%
261,800 $23.9 Million
Q1 2020

May 04, 2020

BUY
$62.82 - $91.86 $12.1 Million - $17.7 Million
192,400 Added 472.73%
233,100 $18.4 Million
Q4 2019

Feb 12, 2020

SELL
$78.51 - $87.4 $157,020 - $174,800
-2,000 Reduced 4.68%
40,700 $3.54 Million
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $196,416 - $212,976
-2,400 Reduced 5.32%
42,700 $3.57 Million
Q2 2019

Aug 07, 2019

SELL
$72.88 - $85.0 $524,736 - $612,000
-7,200 Reduced 13.77%
45,100 $3.79 Million
Q1 2019

May 08, 2019

SELL
$66.22 - $80.06 $443,674 - $536,402
-6,700 Reduced 11.36%
52,300 $4.18 Million
Q4 2018

Feb 11, 2019

SELL
$65.56 - $74.27 $635,932 - $720,419
-9,700 Reduced 14.12%
59,000 $4.27 Million
Q3 2018

Nov 07, 2018

BUY
$60.81 - $73.36 $4.18 Million - $5.04 Million
68,700 New
68,700 $5.04 Million
Q1 2018

May 09, 2018

SELL
$56.27 - $63.62 $3.6 Million - $4.07 Million
-63,900 Closed
0 $0
Q4 2017

Feb 08, 2018

BUY
$53.68 - $57.47 $279,136 - $298,844
5,200 Added 8.86%
63,900 $3.65 Million
Q3 2017

Oct 31, 2017

BUY
$48.06 - $53.64 $2.82 Million - $3.15 Million
58,700
58,700 $3.13 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Forsta Ap Fonden Portfolio

Follow Forsta Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.